$COLD
AMERICOLD REALTY TRUST Stock $cold

$cold Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023015697 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$649.6M	$676.5M
YoY Change	-10.98%	-4.14%
Cost Of Revenue	$465.6M	$488.9M
YoY Change	-17.08%	-10.68%
Gross Profit	$184.1M	$187.6M
YoY Change	9.36%	18.5%
Gross Profit Margin	28.33%	27.73%
Selling, General & Admin	$53.79M	$62.86M
YoY Change	-4.42%	9.12%
% of Gross Profit	29.22%	33.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$84.89M	$85.02M
YoY Change	2.66%	2.91%
% of Gross Profit	46.12%	45.33%
Operating Expenses	$138.7M	$62.86M
YoY Change	146.44%	9.12%
Operating Profit	$45.37M	$32.35M
YoY Change	91.73%	304.82%
Interest Expense	-$37.14M	-$37.45M
YoY Change	-239.91%	-245.31%
% of Operating Profit	-81.85%	-115.77%
Other Income/Expense, Net	-$56.99M	$1.433M
YoY Change	1136.52%	484.9%
Pretax Income	-$96.06M	-$4.215M
YoY Change	1083.62%	-76.78%
Income Tax	$464.0K	-$1.644M
% Of Pretax Income
Net Earnings	-$104.7M	-$2.562M
YoY Change	-2761.35%	-85.28%
Net Earnings / Revenue	-16.12%	-0.38%
Basic Earnings Per Share	-$0.39	-$0.01
Diluted Earnings Per Share	-$0.38	-$0.01
COMMON SHARES
Basic Shares Outstanding	270.2M shares	269.9M shares
Diluted Shares Outstanding	270.5M shares	270.2M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$48.87M	$47.22M
YoY Change	-34.5%	-7.34%
Cash & Equivalents	$48.87M	$47.22M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$465.6M	$409.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$514.4M	$456.8M
YoY Change	6.58%	-2.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.413B	$5.058B
YoY Change	7.0%	-1.61%
Goodwill	$1.036B	$1.031B
YoY Change	-0.42%	-3.55%
Intangibles	$914.2M	$918.9M
YoY Change	-3.17%	-5.08%
Long-Term Investments	$36.96M	$96.72M
YoY Change	-49.03%	122.21%
Other Assets	$106.4M
YoY Change
Total Long-Term Assets	$7.701B	$7.615B
YoY Change	0.64%	-1.58%
TOTAL ASSETS
Total Short-Term Assets	$514.4M	$456.8M
Total Long-Term Assets	$7.701B	$7.615B
Total Assets	$8.216B	$8.072B
YoY Change	0.99%	-1.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$527.1M	$479.7M
YoY Change	-4.96%	-10.43%
Accrued Expenses	$255.8M	$257.8M
YoY Change	-9.6%	-11.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$782.9M	$737.5M
YoY Change	-6.53%	-10.78%
LONG-TERM LIABILITIES
Long-Term Debt	$3.557B	$3.438B
YoY Change	10.69%	7.27%
Other Long-Term Liabilities	$153.2M	$42.22M
YoY Change	266.99%	6.88%
Total Long-Term Liabilities	$3.710B	$3.480B
YoY Change	13.98%	7.27%
TOTAL LIABILITIES
Total Short-Term Liabilities	$782.9M	$737.5M
Total Long-Term Liabilities	$3.710B	$3.480B
Total Liabilities	$4.641B	$4.350B
YoY Change	9.56%	2.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.642B	-$1.477B
YoY Change	27.23%	19.64%
Common Stock	$2.702M	$2.701M
YoY Change	0.33%	0.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.575B	$3.705B
YoY Change
Total Liabilities & Shareholders Equity	$8.216B	$8.072B
YoY Change	0.99%	-1.66%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$104.7M	-$2.562M
YoY Change	-2761.35%	-85.28%
Depreciation, Depletion And Amortization	$84.89M	$85.02M
YoY Change	2.66%	2.91%
Cash From Operating Activities	$41.29M	$41.48M
YoY Change	-64.91%	166.14%
INVESTING ACTIVITIES
Capital Expenditures	$78.79M	$69.26M
YoY Change	-182.45%	-25.54%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	$3.711M	-$18.33M
YoY Change	-272.52%	1397.55%
Cash From Investing Activities	-$75.08M	-$87.59M
YoY Change	-23.16%	-7.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	37.65M	$38.87M
YoY Change	531.33%	-15.97%
NET CHANGE
Cash From Operating Activities	41.29M	$41.48M
Cash From Investing Activities	-75.08M	-$87.59M
Cash From Financing Activities	37.65M	$38.87M
Net Change In Cash	3.851M	-$7.244M
YoY Change	-85.13%	-77.64%
FREE CASH FLOW
Cash From Operating Activities	$41.29M	$41.48M
Capital Expenditures	$78.79M	$69.26M
Free Cash Flow	-$37.51M	-$27.78M
YoY Change	-117.59%	-64.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001455863
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#Revenues
CY2022Q1	us-gaap	Operating Lease Income Comprehensive Income Extensible List OperatingLeaseIncomeComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#Revenues
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32900000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32000000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34723
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICOLD REALTY TRUST, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-0295215
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	10 Glenlake Parkway,
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600, South Tower
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30328
CY2023Q1	dei	City Area Code CityAreaCode	678
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	441-1400
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	COLD
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	270164244	shares
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7029998000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6967267000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1971897000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1901450000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5058101000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5065817000	usd
CY2023Q1	art	Operating Lease Rightof Use Asset Gross OperatingLeaseRightofUseAssetGross	352442000	usd
CY2022Q4	art	Operating Lease Rightof Use Asset Gross OperatingLeaseRightofUseAssetGross	352553000	usd
CY2023Q1	art	Operating Lease Rightofuse Asset Accumulated Depreciation OperatingLeaseRightofuseAssetAccumulatedDepreciation	84172000	usd
CY2022Q4	art	Operating Lease Rightofuse Asset Accumulated Depreciation OperatingLeaseRightofuseAssetAccumulatedDepreciation	76334000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	268270000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	276219000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	145790000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	140555000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	61180000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	57626000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	84610000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	82929000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47222000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53063000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17411000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	15951000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	409530000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	430042000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	918945000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	925223000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	1030562000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1033637000	usd
CY2023Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	96717000	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	78926000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	157761000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	158705000	usd
CY2023Q1	us-gaap	Assets Assets	8071718000	usd
CY2022Q4	us-gaap	Assets Assets	8104561000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	610500000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	500052000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	479738000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	557540000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	2580441000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	2569281000	usd
CY2023Q1	art	Sale Leaseback Transaction Liability SaleLeasebackTransactionLiability	168919000	usd
CY2022Q4	art	Sale Leaseback Transaction Liability SaleLeasebackTransactionLiability	171089000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	78421000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	77561000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	257791000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	264634000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32921000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32046000	usd
CY2023Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent	1564000	usd
CY2022Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current And Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrentAndNoncurrent	1531000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	132415000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	135098000	usd
CY2023Q1	us-gaap	Multiemployer Plans Withdrawal Obligation MultiemployerPlansWithdrawalObligation	7731000	usd
CY2022Q4	us-gaap	Multiemployer Plans Withdrawal Obligation MultiemployerPlansWithdrawalObligation	7851000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4350441000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4316683000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	270096433	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	270096433	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	269814956	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	269814956	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2701000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2698000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5197893000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5191969000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1477452000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1415198000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17737000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6050000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3705405000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3773419000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	15872000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	14459000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3721277000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3787878000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8071718000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8104561000	usd
CY2023Q1	art	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs And Discounts And Below Market Leases DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCostsAndDiscountsAndBelowMarketLeases	85024000	usd
CY2022Q1	art	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs And Discounts And Below Market Leases DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCostsAndDiscountsAndBelowMarketLeases	82620000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62855000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57602000	usd
CY2023Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	7147000	usd
CY2022Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	10075000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-191000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	644140000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	697704000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	32349000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7991000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	34423000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	25773000	usd
CY2023Q1	art	Gain Loss On Extinguishment Of Debt And Termination Of Derivatives GainLossOnExtinguishmentOfDebtAndTerminationOfDerivatives	-545000	usd
CY2022Q1	art	Gain Loss On Extinguishment Of Debt And Termination Of Derivatives GainLossOnExtinguishmentOfDebtAndTerminationOfDerivatives	-616000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1433000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2357000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3029000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2112000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4215000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18153000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1977000	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1181000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3621000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1889000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1644000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-708000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2571000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-17445000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2562000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17407000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	270230000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	269164000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	270230000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	269164000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2571000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-17445000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-698000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-67000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	179000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	11186000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-12564000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	151000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11687000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	11404000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	35000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-23000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14293000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6018000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3787878000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2571000	usd
CY2023Q1	art	Other Comprehensive Income Loss Netof Tax Portion Attributableto Parent Excluding Hyperinflation Adjustment OtherComprehensiveIncomeLossNetofTaxPortionAttributabletoParentExcludingHyperinflationAdjustment	-11722000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	59932000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6970000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-799000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1453000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3721277000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4029076000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-17445000	usd
CY2022Q1	art	Other Comprehensive Income Loss Netof Tax Portion Attributableto Parent Excluding Hyperinflation Adjustment OtherComprehensiveIncomeLossNetofTaxPortionAttributabletoParentExcludingHyperinflationAdjustment	11427000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	59760000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8093000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-2137000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1985000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3971239000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2571000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-17445000	usd
CY2023Q1	art	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs And Discounts And Below Market Leases DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCostsAndDiscountsAndBelowMarketLeases	85024000	usd
CY2022Q1	art	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs And Discounts And Below Market Leases DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCostsAndDiscountsAndBelowMarketLeases	82620000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1240000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1146000	usd
CY2023Q1	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	402000	usd
CY2022Q1	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	508000	usd
CY2023Q1	art	Gain Losson Extinguishmentof Debt Noncash GainLossonExtinguishmentofDebtNoncash	-545000	usd
CY2022Q1	art	Gain Losson Extinguishmentof Debt Noncash GainLossonExtinguishmentofDebtNoncash	-616000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	458000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	325000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3029000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2112000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6970000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8093000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	69262000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3621000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1889000	usd
CY2023Q1	art	Gain Losson Dispositionof Property Plant Equipment Netof Tax GainLossonDispositionofPropertyPlantEquipmentNetofTax	-191000	usd
CY2022Q1	art	Gain Losson Dispositionof Property Plant Equipment Netof Tax GainLossonDispositionofPropertyPlantEquipmentNetofTax	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	156000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	165000	usd
CY2023Q1	art	Accounts Receivable Credit Loss Expense Reversal Non Cash AccountsReceivableCreditLossExpenseReversalNonCash	1458000	usd
CY2022Q1	art	Accounts Receivable Credit Loss Expense Reversal Non Cash AccountsReceivableCreditLossExpenseReversalNonCash	1970000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20012000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41994000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-69996000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-35572000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	588000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-15911000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41481000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15586000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3226000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93020000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-603000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	18400000	usd
CY2022Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1925000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	70000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	98000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87592000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94244000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	60064000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	59940000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1464000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	575000	usd
CY2023Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1452000	usd
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1985000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2265000	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	186700000	usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	115000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	76604000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023Q1	art	Sale Leaseback Transaction Repayment Financing Activities SaleLeasebackTransactionRepaymentFinancingActivities	2170000	usd
CY2022Q1	art	Sale Leaseback Transaction Repayment Financing Activities SaleLeasebackTransactionRepaymentFinancingActivities	1619000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9646000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4695000	usd
CY2023Q1	art	Repayments Of Medium Term Debt And Secured Debt RepaymentsOfMediumTermDebtAndSecuredDebt	0	usd
CY2022Q1	art	Repayments Of Medium Term Debt And Secured Debt RepaymentsOfMediumTermDebtAndSecuredDebt	1824000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38867000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	46256000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7244000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-32402000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1403000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	409000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53063000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82958000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47222000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50965000	usd
CY2023Q1	art	Noncashor Part Noncash Acquisition Fixed Assets Not Under Capital Lease Obligations Acquired NoncashorPartNoncashAcquisitionFixedAssetsNotUnderCapitalLeaseObligationsAcquired	40467000	usd
CY2022Q1	art	Noncashor Part Noncash Acquisition Fixed Assets Not Under Capital Lease Obligations Acquired NoncashorPartNoncashAcquisitionFixedAssetsNotUnderCapitalLeaseObligationsAcquired	52931000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	10486000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	5717000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	474000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1828000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	47387000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	38751000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	556000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2252000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of (1) assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements, and (2) revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	1786000	usd
CY2022Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	6285000	usd
CY2023Q1	art	Project Acquisition Expenses ProjectAcquisitionExpenses	1946000	usd
CY2022Q1	art	Project Acquisition Expenses ProjectAcquisitionExpenses	0	usd
CY2023Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2022Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1200000	usd
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	3415000	usd
CY2022Q1	us-gaap	Severance Costs1 SeveranceCosts1	2564000	usd
CY2023Q1	art	Cyber Incident Related Costs CyberIncidentRelatedCosts	0	usd
CY2022Q1	art	Cyber Incident Related Costs CyberIncidentRelatedCosts	26000	usd
CY2023Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	7147000	usd
CY2022Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	10075000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3203375000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3082377000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0094
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0095
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	14867000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	23520000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2435000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-8564000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	-4325000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	4000000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-4476000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	14867000	usd
CY2023Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	14867000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	1343000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	13524000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2435000	usd
CY2023Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2435000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1343000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	1092000	usd
CY2022Q4	us-gaap	Derivative Asset Not Subject To Master Netting Arrangement DerivativeAssetNotSubjectToMasterNettingArrangement	0	usd
CY2022Q4	us-gaap	Derivative Liability Not Subject To Master Netting Arrangement DerivativeLiabilityNotSubjectToMasterNettingArrangement	0	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	41600000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	105498	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.81
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	105498	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	105498	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.81
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	206298	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	40900	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.81
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	165398	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.81
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	165398	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.81
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	270230000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	269164000	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M6D
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	85024000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82620000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	62855000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57602000	usd
CY2023Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	7147000	usd
CY2022Q1	art	Business Combination Acquisition Related Expenses Litigations Expenseand Other BusinessCombinationAcquisitionRelatedExpensesLitigationsExpenseandOther	10075000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-191000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	34423000	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	25773000	usd
CY2023Q1	art	Gain Loss On Extinguishment Of Debt And Termination Of Derivatives GainLossOnExtinguishmentOfDebtAndTerminationOfDerivatives	-545000	usd
CY2022Q1	art	Gain Loss On Extinguishment Of Debt And Termination Of Derivatives GainLossOnExtinguishmentOfDebtAndTerminationOfDerivatives	-616000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1433000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2357000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3029000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2112000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4215000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18153000	usd
CY2023Q1	us-gaap	Assets Assets	8071718000	usd
CY2022Q4	us-gaap	Assets Assets	8104561000	usd
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	270230000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	269164000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	108000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1991000	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	664075000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	12414000	usd
CY2023Q1	us-gaap	Revenues Revenues	676489000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	694903000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	10792000	usd
CY2022Q1	us-gaap	Revenues Revenues	705695000	usd
CY2023Q1	art	Revenue Performance Obligation Satisfiedover Time Variable Consideration Constrained Percentage RevenuePerformanceObligationSatisfiedoverTimeVariableConsiderationConstrainedPercentage	1
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	649700000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.24
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.76
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P11Y3M18D
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	402100000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	421100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32900000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32000000	usd

Files In Submission

Name	View Source	Status
art-20230331_cal.xml	Edgar Link	unprocessable
art-20230331_lab.xml	Edgar Link	unprocessable
0001628280-23-015697-index-headers.html	Edgar Link	pending
0001628280-23-015697-index.html	Edgar Link	pending
0001628280-23-015697.txt	Edgar Link	pending
0001628280-23-015697-xbrl.zip	Edgar Link	pending
art-20230331.htm	Edgar Link	pending
art-20230331.xsd	Edgar Link	pending
exhibit311q123.htm	Edgar Link	pending
exhibit312q123.htm	Edgar Link	pending
exhibit321q123.htm	Edgar Link	pending
exhibit322q123.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
art-20230331_def.xml	Edgar Link	unprocessable
art-20230331_pre.xml	Edgar Link	unprocessable
art-20230331_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COLD
AMERICOLD REALTY TRUST Stock $cold

2023 Q2 Form 10-Q Financial Statement

#000162828023015697 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLD AMERICOLD REALTY TRUST Stock $cold

2023 Q2 Form 10-Q Financial Statement

#000162828023015697 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLD
AMERICOLD REALTY TRUST Stock $cold